Borsini F, Giuliani S, Meli A
A. Menarini s.a.s., Research Division, Firenze, Italia.
Pharmacol Biochem Behav. 1988 Jan;29(1):189-91. doi: 10.1016/0091-3057(88)90294-8.
Subcutaneous chronic desipramine (DMI, 5 mg/kg once daily for 18 consecutive days) prevented subcutaneous THIP (20 mg/kg) reduction in body temperature but did not affect THIP behavioral depressant effect (open-field behavior). Repeated DMI treatment did not affect subcutaneous baclofen (2.5-10 mg/kg) reduction in body temperature and behavioral depression (open-field behavior).
皮下注射慢性给予去甲丙咪嗪(DMI,5毫克/千克,每日一次,连续18天)可防止皮下注射THIP(20毫克/千克)引起的体温降低,但不影响THIP的行为抑制作用(旷场行为)。重复给予DMI治疗不影响皮下注射巴氯芬(2.5 - 10毫克/千克)引起的体温降低和行为抑制(旷场行为)。